Shabbir Ahmad

Shabbir Ahmad

Auto-generated profile, based on publicly available information

Shabbir Ahmad

Structural Genomics Consortium, University Health Network, Toronto, Canada

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 February 2013 in Biochemistry
Verified
Journal Article
Open access
SAShabbir Ahmad
Shabbir Ahmad
DNDamian Niegowski
Damian Niegowski
AWAnders Wetterholm
Anders Wetterholm
JHJesper Z. Haeggström
Jesper Z. Haeggström
RMRalf Morgenstern
Ralf Morgenstern
ARAgnes Rinaldo-Matthis
Agnes Rinaldo-Matthis
Microsomal glutathione S-transferase 2 (MGST2) is a 17 kDa trimeric integral membrane protein homologous to leukotriene C4 synthase (LTC4S). MGST2 has been suggested to catalyze the biosynthesis of the pro-inflammatory mediator leukotriene C4 (LTC4) in cells devoid of LTC4S. A detailed biochemical study of MGST2 is critical for the understanding of its cellular function and potential role as an LTC4-producing enzyme. Here we have characterized the substrate specificity and catalytic properties of purified MGST2 by steady-state and pre-steady-state kinetic experiments. In comparison with LTC4S, which has a catalytic efficiency of 8.7 × 105 M–1 s–1, MGST2, with a catalytic efficiency of 1.8 × 104 M–1 s–1, is considerably less efficient in producing LTC4. However, the two enzymes display a similar KMLTA4 of 30–40 μM. While LTC4S has one activated glutathione (GSH) (forming a thiolate) per enzyme monomer, the MGST2 trimer seems to display only third-of-the-sites reactivity for thiolate activation, which in part would explain its lower catalytic efficiency. Furthermore, MGST2 displays GSH-dependent peroxidase activity of ∼0.2 μmol min–1 mg–1 toward several lipid hydroperoxides. MGST2, but not LTC4S, is efficient in catalyzing conjugation of the electrophilic substrate 1-chloro-2,4-dinitrobenzene (CDNB) and the lipid peroxidation product 4-hydroxy-2-nonenal with GSH. Using stopped-flow pre-steady-state kinetics, we have characterized the full catalytic reaction of MGST2 with CDNB and GSH as substrates, showing an initial rapid equilibrium binding of GSH followed by thiolate formation. Burst kinetics for the CDNB–GSH conjugation step was observed only at low GSH concentrations (thiolate anion formation becoming rate-limiting under these conditions). Product release is rapid and does not limit the overall reaction. Therefore, in general, the chemical conjugation step is rate-limiting for MGST2 at physiological GSH concentrations. MGST2 and LTC4S exhibit distinct catalytic and mechanistic properties, reflecting adaptation to broad and specific physiological functions, respectively.

19 March 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
MTMadhuranayaki Thulasingam
Madhuranayaki Thulasingam
LOLaura Orellana
Laura Orellana
ENEmmanuel Nji
Emmanuel Nji
SAShabbir Ahmad
Shabbir Ahmad
ARAgnes Rinaldo-Matthis
Agnes Rinaldo-Matthis
JHJesper Z. Haeggström
Jesper Z. Haeggström
Microsomal glutathione S-transferase 2 (MGST2) produces leukotriene C4, key for intracrine signaling of endoplasmic reticulum (ER) stress, oxidative DNA damage and cell death. MGST2 trimer restricts catalysis to only one out of three active sites at a time, but the molecular basis is unknown. Here, we present crystal structures of human MGST2 combined with biochemical and computational evidence for a concerted mechanism, involving local unfolding coupled to global conformational changes that regulate catalysis. Furthermore, synchronized changes in the biconical central pore modulate the hydrophobicity and control solvent influx to optimize reaction conditions at the active site. These unique mechanistic insights pertain to other, structurally related, drug targets.

5 April 2024 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
DHDouglas L. Huseby
Douglas L. Huseby
SCSha Cao
Sha Cao
EZEdouard Zamaratski
Edouard Zamaratski
SSSanjeewani Sooriyaarachchi
Sanjeewani Sooriyaarachchi
SAShabbir Ahmad
Shabbir Ahmad
AKAnders Karlén
Anders Karlén
Here, we describe the identification of an antibiotic class acting via LpxH, a clinically unexploited target in lipopolysaccharide synthesis. The lipopolysaccharide synthesis pathway is essential in most Gram-negative bacteria and there is no analogous pathway in humans. Based on a series of phenotypic screens, we identified a hit targeting this pathway that had activity on efflux-defective strains of Escherichia coli . We recognized common structural elements between this hit and a previously published inhibitor, also with activity against efflux-deficient bacteria. With the help of X-ray structures, this information was used to design inhibitors with activity on efflux-proficient, wild-type strains. Optimization of properties such as solubility, metabolic stability and serum protein binding resulted in compounds having potent in vivo efficacy against bloodstream infections caused by the critical Gram-negative pathogens E. coli and Klebsiella pneumoniae . Other favorable properties of the series include a lack of pre-existing resistance in clinical isolates, and no loss of activity against strains expressing extended-spectrum-β-lactamase, metallo-β-lactamase, or carbapenemase-resistance genes. Further development of this class of antibiotics could make an important contribution to the ongoing struggle against antibiotic resistance.

1 February 2014 in Journal of Biological Chemistry
Verified
Journal Article
Open access
DNDamian Niegowski
Damian Niegowski
TKThea Kleinschmidt
Thea Kleinschmidt
UOUlrika Olsson
Ulrika Olsson
SAShabbir Ahmad
Shabbir Ahmad
ARAgnes Rinaldo-Matthis
Agnes Rinaldo-Matthis
JHJesper Z. Haeggström
Jesper Z. Haeggström
Leukotriene (LT) C4 synthase (LTC4S) catalyzes the conjugation of the fatty acid LTA4 with the tripeptide GSH to produce LTC4, the parent compound of the cysteinyl leukotrienes, important mediators of asthma. Here we mutated Trp-116 in human LTC4S, a residue proposed to play a key role in substrate binding, into an Ala or Phe. Biochemical and structural characterization of these mutants along with crystal structures of the wild type and mutated enzymes in complex with three product analogs, viz. S-hexyl-, 4-phenyl-butyl-, and 2-hydroxy-4-phenyl-butyl-glutathione, provide new insights to binding of substrates and product, identify a new conformation of the GSH moiety at the active site, and suggest a route for product release, aided by Trp-116.

1 October 2015 in Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
Verified
Journal Article
Closed access
SAShabbir Ahmad
Shabbir Ahmad
MTMadhuranayaki Thulasingam
Madhuranayaki Thulasingam
IPIsolde Palombo
Isolde Palombo
DDDaniel Daley
Daniel Daley
KJKenneth A. Johnson
Kenneth A. Johnson
ARAgnes Rinaldo-Matthis
Agnes Rinaldo-Matthis

1 March 2010 in Archives of Biochemistry and Biophysics
Verified
Journal Article
Closed access
DLDiana Lindberg
Diana Lindberg
SAShabbir Ahmad
Shabbir Ahmad
MWMikael Widersten
Mikael Widersten